Pacific Biosciences Stock Target Price and Analyst Consensus

PACB Stock  USD 3.75  0.03  0.81%   
The current analyst and expert consensus on Pacific Biosciences is Buy with 5 hold recommendations. The current projected Pacific Biosciences target price consensus is 13.77 with 13 analyst opinions. One of the most common ways Pacific Biosciences analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Pacific Biosciences vendors, executives, and/or customers. Pacific Biosciences recommendation module provides expert sentiment on the projected Pacific Biosciences target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Pacific Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Pacific Stock refer to our How to Trade Pacific Stock guide.
Lowest Forecast
12.53
Highest Forecast
15.28
Target Price
13.77
The current year's Gross Profit Margin is expected to grow to 0.29, whereas Gross Profit is forecasted to decline to about 27.3 M. At present, Pacific Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Total Assets is expected to grow to about 1.8 B, whereas Other Liabilities is forecasted to decline to about 2.8 M.
  
It's important to approach Pacific Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Pacific Biosciences Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pacific target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Pacific Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   13  Buy
Most Pacific analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Pacific stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Pacific Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Pacific Biosciences Target Price Projection

Pacific Biosciences' current and average target prices are 3.75 and 13.77, respectively. The current price of Pacific Biosciences is the price at which Pacific Biosciences is currently trading. On the other hand, Pacific Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Pacific Biosciences Market Quote on 29th of March 2024

Low Price3.68Odds
High Price3.89Odds

3.75

Target Price

Analyst Consensus On Pacific Biosciences Target Price

Low Estimate12.53Odds
High Estimate15.28Odds

13.77

Historical Lowest Forecast  12.53 Target Price  13.77 Highest Forecast  15.28
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Pacific Biosciences and the information provided on this page.

Pacific Biosciences Analyst Ratings

Pacific Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Pacific Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Pacific Biosciences' financials, market performance, and future outlook by experienced professionals. Pacific Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Pacific Biosciences price targets

Pacific Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Pacific Biosciences' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Pacific Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Pacific Biosciences' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Pacific Biosciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pacific Biosciences is a key component of Pacific Biosciences valuation and have some predictive power on the future returns of a Pacific Biosciences.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.204.059.51
Details
Intrinsic
Valuation
LowRealHigh
0.766.2211.68
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.3-0.27-0.23
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pacific Biosciences. Your research has to be compared to or analyzed against Pacific Biosciences' peers to derive any actionable benefits. When done correctly, Pacific Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pacific Biosciences.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cleaning Idea
Cleaning
Invested over 100 shares
Business Services Idea
Business Services
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Stock:
Check out Macroaxis Advice on Pacific Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Pacific Stock refer to our How to Trade Pacific Stock guide.
Note that the Pacific Biosciences information on this page should be used as a complementary analysis to other Pacific Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Pacific Stock analysis

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
The data published in Pacific Biosciences' official financial statements usually reflect Pacific Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Pacific Biosciences. For example, before you start analyzing numbers published by Pacific accountants, it's critical to develop an understanding of what Pacific Biosciences' liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Pacific Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pacific Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Pacific Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pacific Biosciences. Please utilize our Beneish M Score to check the likelihood of Pacific Biosciences' management manipulating its earnings.